Mycophenolate Mofetil and Cyclophosphamide Treatments Suppress Inflammation Intensity in an Experimental Model of Autoimmune Uveitis

Abstract

In human autoimmune uveitis is a leading cause of visual disability and ranks with diabetic retinopath\y as a major source of blind registrations in developed countries. Since most cases of non.infectious uveitis are considered to be autoimmune or at least immune-mediated,the management of such patients has rested on appropriate immunosupressions.

Keywords

• experimental autoimmune uveitis
• autoimmunity
• retinal antigen
• uveitis
• mycophenolate mofetil
• cyclophosphamide
• golimumab